502 related articles for article (PubMed ID: 24986657)
1. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.
Evranos-Aksöz B; Baysal İ; Yabanoğlu-Çiftçi S; Djikic T; Yelekçi K; Uçar G; Ertan R
Arch Pharm (Weinheim); 2015 Oct; 348(10):743-56. PubMed ID: 26293971
[TBL] [Abstract][Full Text] [Related]
3. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
[TBL] [Abstract][Full Text] [Related]
4. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
Evranos-Aksoz B; Ucar G; Yelekci K
Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.
Tong X; Chen R; Zhang TT; Han Y; Tang WJ; Liu XH
Bioorg Med Chem; 2015 Feb; 23(3):515-25. PubMed ID: 25541201
[TBL] [Abstract][Full Text] [Related]
8. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.
D'Ascenzio M; Chimenti P; Gidaro MC; De Monte C; De Vita D; Granese A; Scipione L; Di Santo R; Costa G; Alcaro S; Yáñez M; Carradori S
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):908-19. PubMed ID: 25807300
[TBL] [Abstract][Full Text] [Related]
9. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
[TBL] [Abstract][Full Text] [Related]
11. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
12. Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity.
Goksen US; Sarigul S; Bultinck P; Herrebout W; Dogan I; Yelekci K; Ucar G; Gokhan Kelekci N
Chirality; 2019 Jan; 31(1):21-33. PubMed ID: 30468523
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
[TBL] [Abstract][Full Text] [Related]
14. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
16. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
[TBL] [Abstract][Full Text] [Related]
17. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ
Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; İnci B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Aug; 22(8):. PubMed ID: 28825649
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
